ZBTB8A's Role in Cancer and Diseases (G653121)

Target Name: ZBTB8A

NCBI ID: G653121

ZBTB8A

ZBTB8A's Role in Cancer and Diseases

ZBTB8A (ZNF916A), a transcription factor, is an important component in the Hedgehog signaling pathway. Studies have found that ZBTB8A plays an important role in a variety of cancers, such as skin cancer, liver cancer, and breast cancer. In addition, ZBTB8A is also related to many diseases and drug targets, such as diabetes, neurodegenerative diseases, obesity and liver diseases. These findings provide important clues for studying the role of ZBTB8A and developing new therapeutic strategies.

ZBTB8A is a transcription factor and an important component in the Hedgehog signaling pathway. The Hedgehog signaling pathway is an important cell biology pathway and plays an important role in a variety of biological processes. Research shows that ZBTB8A plays an important role in the Hedgehog signaling pathway and is a key component in the Hedgehog signaling pathway.

ZBTB8A is associated with various cancers. Research shows that ZBTB8A plays an important role in various cancers such as skin cancer, liver cancer, and breast cancer. Knockdown or activation of ZBTB8A can lead to tumor initiation and growth. In addition, ZBTB8A is also related to the metastasis and invasion of tumor cells. These findings provide important clues for studying the role of ZBTB8A and developing new therapeutic strategies.

ZBTB8A has also been linked to many diseases and drug targets. Studies have shown that ZBTB8A is related to various diseases such as diabetes, neurodegenerative diseases, obesity and liver disease. Knockdown or activation of ZBTB8A can lead to symptoms and progression of diseases such as diabetes, neurodegenerative diseases, and liver disease. In addition, ZBTB8A is also related to drug targets, such as anti-diabetic drugs and anti-obesity drugs. These findings provide important clues for studying the role of ZBTB8A and developing new therapeutic strategies.

Knockdown or activation of ZBTB8A can lead to a variety of diseases and symptoms. Studies have shown that knockdown or activation of ZBTB8A can lead to the symptoms and progression of diseases such as diabetes, neurodegenerative diseases, and liver diseases. For example, knockdown of ZBTB8A can lead to the onset and progression of diabetes, while activation of ZBTB8A can lead to the symptoms and progression of neurodegenerative diseases. In addition, knockdown or activation of ZBTB8A can also lead to symptoms and progression of liver disease.

Protein Name: Zinc Finger And BTB Domain Containing 8A

Functions: May be involved in transcriptional regulation

The "ZBTB8A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZBTB8A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets